Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on COVID-19
Melatonin in deadly virus infection
Keywords:
melatonin, virus, innate immunity, inflammation, COVID-19, SARS, MERS, Avian flu, cytokines
Abstract
The high mortality of deadly virus infectious diseases including SARS, MERS, COVID-19, and avian flu is often caused by the uncontrolled innate immune response and destructive inflammation. The majority of viral diseases are self-limiting under the help of the activated adaptive immune system. This activity is cell proliferation dependent and thus, it requires several weeks to develop. Patients are vulnerable and mortality usually occurs during this window period. To control the innate immune response and reduce the inflammation during this period will increase the tolerance of patients and lowers the mortality in the deadly virus infection. Melatonin is a molecule that displays respective properties, since it downregulates the overreaction of the innate immune response and overshooting inflammation, but also promotes the adaptive immune activity. Many studies have reported the beneficial effects of melatonin on deadly virus infections in different animal models and its therapeutic efficacy in septic shock patients. Furthermore, melatonin has a great safety margin without serious adverse effects. We suggest the use of melatonin as an adjunctive or even regular therapy for deadly viral diseases, especially if no efficient direct anti-viral treatment is available.
References
1. Chen CC, et al. (2011) ORF 8a of severe acute respiratory syndrome coronavirus forms an ion channel: experiments and molecular dynamics simulations. Biochim. Biophys. Acta 1808: 572–579.
2. Millet JK, Whittaker GR (2015) Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202: 120–134.
3. de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ (2018) Host factors in coronavirus replication. Curr. Top. Microbiol. Immunol. 419: 1–42.
4. Gao J, Tian Z, Yang X (2020) Breakthrough: Chloroquine phosphate has shown apparent efficiacy in treatment of COVID-19 associated prneumonia in clinical studies. BioSci. Trends 14 (1): 72-73. doi: 10. 5582/bst.2020.01047.
5. Hoffmann M, et al. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. Cell. doi: 10.1016/j.cell.2020.02,052.
6. Chen IY, et al. (2019) Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front. Microbiol. 10: 50.
7. Siu KL, et al. (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 33: 8865–8877.
8. Bancos S, Bernard MP, Topham DJ, Phipps RP (2009) Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell. Immunol. 258: 18–28.
9. Hardeland R (2018) Melatonin and inflammation —Story of a double-edged blade. J. Pineal Res. 65: e12525.
10. Hattori A, et al. (1995) Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int. 35: 627–34.
11. Oba S, Nakamura K, Sahashi Y, Hattori A, Nagata C (2008) Consumption of vegetables alters morning urinary 6-sulfatoxymelatonin concentration. J. Pineal Res. 45: 17–23.
12. Howatson G, et al. (2012) Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur. J. Nutr. 51: 909–916.
13. 13. Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12, 151–180 (1991).
14. Hardeland R (2012) Melatonin in aging and disease ― multiple consequences of reduced secretion, options and limits of treatment. Aging Dis. 3: 194–225.
15. Tan DX, Chen L, Poeggeler B, Manchester LC, Reiter JR (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1: 57–63.
16. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007) One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res. 42: 28–42.
17. Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D (2016) ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid. Med. Cell. Longev. 2016：1–18.
18. Baumann CW, Kwak D, Liu HM, Thompson LV (2016) Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? J. Appl. Physiol. 121: 1047–1052.
19. Pohjanvirta R, Tuomisto J, Linden J, Laitinen J (1989) TCDD Reduces Serum Melatonin Levels in Long-Evans Rats. Pharmacol. Toxicol. 65: 239–240 (1989).
20. Linden J, Pohjanvirta R, Rahko T, Tuomisto J TCDD (1991) Decreases Rapidly and persistently serum melatonin concentration without morphologically affecting the pineal gland in TCDD-resistant Han/Wistar rats. Pharmacol. Toxicol. 69: 427–432.
21. Pohjanvirta R, et al. (1996) Mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology 107: 85–97.
22. Ozcankaya, Delibas N (2002) Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat. Med. J. 43: 28–32.
23. Uchida K, Okamoto N, Ohara K, Morita Y (1996) Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717: 154–159.
24. Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ (2012) Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J. Pineal Res. 53: 319–323.
25. Dzida G, et al. (2013) Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. Ann. Agric. Environ. Med. 20: 745–748.
26. Hardeland R (2012) Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Scientific World Journal 2012: 640389.
27. Uz T, Qu T, Sugaya K, Manev H (2002) Neuronal expression of arylalkylamine N-acetyltransferase (AANAT) mRNA in the rat brain. Neurosci. Res. 42: 309–316.
28. Klein DC, et al. (2002) 14-3-3 Proteins and photoneuroendocrine transduction: role in controlling the daily rhythm in melatonin. Biochem. Soc. Trans. 30: 365–373.
29. Hardeland R (2008) Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. 65: 2001–2018.
30. Hardeland R, et al. (2011) Melatonin – A pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 93: 350–384.
31. Tan DX, et al. (2013) Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin’s primary function and evolution in eukaryotes. J. Pineal Res. 54: 127–138.
32. Tan DX, Reiter RJ (2019) Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2: 44–66.
33. Suofu Y, et al. (2017) Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proc. Natl. Acad. Sci. 114: E7997–E8006.
34. Huether G (1993)The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 49: 665–670.
35. Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 47: 2336–2348.
36. Hardeland R (2017) Melatonin and the electron transport chain. Cell. Mol. Life Sci. 74: 3883–3896.
37. Hardeland R, et al. (1995) On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18: 104–111.
38. Tan DX, et al. (2010) The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev. Camb. Philos. Soc. 85: 607–623.
39. Boehm T, Swann JB (2014) Origin and evolution of adaptive immunity. Annu. Rev. Anim. Biosci. 2: 259–283.
40. Buchon N, et al. (2014) Immunity in Drosophila melanogaster—from microbial recognition to whole-organism physiology. Nat. Rev. Immunol. 14: 796–810.
41. Zhang X, Soldati T (2016) Of amoebae and men: Extracellular DNA traps as an ancient cell-Intrinsic defense mechanism. Front. Immunol. 7: 269.
42. Tan DX (2019) Aging: An evolutionary competition between host cells and mitochondria. Med. Hypotheses 127: 120–128.
43. Csaba G (2013) The pineal regulation of the immune system: 40 years since the discovery. Acta Microbiol. Immunol. Hung. 60: 77–91.
44. Mańka S, Majewska E (2016) Immunoregulatory action of melatonin. The mechanism of action and the effect on inflammatory cells. Postepy Hig. Med. Dosw. 70: 1059–1067.
45. Markus RP, Fernandes PA, Kinker GS, da Silveira Cruz-Machado S, Marçola M (2018) Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br. J. Pharmacol. 175: 3239–3250.
46. Boga, JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ (2012) Beneficial actions of melatonin in the management of viral infections: a new use for this “molecular handyman”? Rev. Med. Virol. 22: 323–338.
47. Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR (2015) Melatonin and brain inflammaging. Prog. Neurobiol. 127–128: 46–63.
48. Hardeland R. (2019) Aging, melatonin, and the pro- and anti-inflammatory networks. Int. J. Mol. Sci. 20: 1223.
49. Xia Y, et al. (2019) Melatonin in macrophage biology: Current understanding and future perspectives. J. Pineal Res. 66: e12547.
50. Lu R, et al. (2019) Melatonin is responsible for rice resistance to rice stripe virus infection through a nitric oxide-dependent pathway. Virol. J. 16: 141.
51. Ouyang H, et al. (2019) Inhibitory effect of melatonin on Mst1 ameliorates myocarditis through attenuating ER stress and mitochondrial dysfunction. J. Mol. Histol. 50: 405–415.
52. Kılınçel Ö, et al. (2019) The effect of melatonin on antifungal susceptibility in planktonic and biofilm forms of Candida strains isolated from clinical samples. Med. Mycol. 57: 45–51.
53. Bishayi B, Adhikary R, Nandi A, Sultana S (2016) Beneficial Effects of exogenous melatonin in acute staphylococcus aureus and escherichia coli infection-induced inflammation and associated behavioral response in mice after exposure to short photoperiod. Inflammation 39: 2072–2093.
54. Safari F, et al. (2020) The interaction of phages and bacteria: the co-evolutionary arms race. Crit. Rev. Biotechnol. 40: 119–137.
55. Prangishvili D, et al. (2017) The enigmatic archaeal virosphere. Nat. Rev. Microbiol. 15, 724–739.
56. Aiewsakun P, et al. (2018) Evaluation of the genomic diversity of viruses infecting bacteria, archaea and eukaryotes using a common bioinformatic platform: steps towards a unified taxonomy. J. Gen. Virol. 99: 1331–1343.
57. Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167–170.
58. Bhaya D, Davison M, Barrangou R (2011) CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu. Rev. Genet. 45: 273–297.
59. Hampton HG, Watson BNJ, Fineran PC (2020) The arms race between bacteria and their phage foes. Nature 577: 327–336.
60. Kumar MS, Chen KC (2012) Evolution of animal Piwi-interacting RNAs and prokaryotic CRISPRs. Evolution of animal Piwi-interacting RNAs and prokaryotic CRISPRs. Brief Funct. Genomics 11: 277–288.
61. Ophinni Y, Palatini U, Hayashi Y, Parrish NF (2019) piRNA-guided CRISPR-like immunity in eukaryotes. Trends Immunol. 40: 998–1010.
62. Danilova N (2006) The evolution of immune mechanisms. J. Exp. Zool. Part B Mol. Dev. Evol. 306B: 496–520.
63. Amano A, Nakagawa I, Yoshimori T (2006) Autophagy in innate immunity against intracellular bacteria. J. Biochem. 140: 161–166.
64. Shimada K, et al. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401–414.
65. Glück S, Ablasser A (2018) Innate immunosensing of DNA in cellular senescence. Curr. Opin. Immunol. 56: 31–36.
66. Ma Z, Ni G, Damania B (2018) Innate sensing of DNA virus genomes. Annu. Rev. Virol. 5: 341–362.
67. Rongvaux A (2018) Innate immunity and tolerance toward mitochondria. Mitochondrion 41: 14–20.
68. Boehm T, et al. (2018) Evolution of alternative adaptive immune systems in vertebrates. Annu. Rev. Immunol. 36: 19–42.
69. Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultz, JL (2019) Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens. Cell Host Microbe 25: 13–26.
70. Brilot F, Strowig T, Munz C (2008) NK cells interactions with dendritic cells shape innate and adaptive immunity. Front. Biosci. 13: 6443–6454.
71. Reschner A, et al. (2008) Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin. Exp. Immunol. 152: 219–226.
72. Moretta L, et al. (2006) Surface NK receptors and their ligands on tumor cells.Semin. Immunol. 18: 151-158.
73. Rajalingam R (2018) Diversity of killer cell immunoglobulin-like receptors and disease. Clin. Lab. Med. 38: 637-653.
74. Kumar V, McNerney ME (2005) A new self: MHC-class-I-independent Natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5, 363–374.
75. Lodoen MB, Lanier LL (2005) Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3: 59–69.
76. Werling D, Jungi TW (2003) TOLL-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 91: 1–12.
77. Luecke S, Paludan SR (2015) Innate recognition of alphaherpesvirus DNA. Adv. Virus Res. 92: 63–100.
78. Sepehri Z, Kiani Z, Alavian SM, Arababadi MK, Kennedy D (2016) The link between TLR7 signaling and hepatitis B virus infection. Life Sci. 158: 63–69.
79. Petes C, Odoardi N, Gee K (2017) The toll for trafficking: toll-like receptor 7 delivery to the endosome. Front. Immunol. 8: 1075.
80. Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol. Rev. 227: 75–86.
81. Zhou L, et al. (2015) Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Mol. Hum. Reprod. 21: 917–929.
82. Muruve DA, et al. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103–107.
83. Roberts TL, et al. (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057–1060.
84. Broz P, Dixit VM (2016) Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16: 407–420.
85. Winsor N, et al. (2019) Canonical and noncanonical inflammasomes in intestinal epithelial cells. Cell. Microbiol. 21: e13079.
86. Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA (2019) MERS coronavirus outbreak: Implications for emerging viral infections. Diagn. Microbiol. Infect. Dis. 93: 265–285.
87. Rojek AM, et al. (2019) A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic. Clin. Microbiol. Infect. 25: 1307–1314.
88. Chen J, Subbarao K (2007) The Immunobiology of SARS. Annu. Rev. Immunol. 25: 443–472.
89. Paget J, et al. (2019) Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J. Glob. Health 9: 020421.
90. Messaoudi I, Amarasinghe GK, Basler CF (2015) Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 13: 663–676.
91. Baseler L, et al. (2017) The pathogenesis of Ebola virus disease. Annu. Rev. Pathol. 12: 387-418.
92. Oldstone MBA, Rosen H (2014) Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. in Current topics in microbiology and immunology 378: 129–147.
93. Wong JP, et al. (2017) Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med. Chem. 9: 169–178.
94. Refardt D, Kümmerli R (2013) Defying bacteriophages: Contrasting altruistic with individual-based resistance mechanisms in Escherichia coli. Commun. Integr. Biol. 6: e25159.
95. Pavlovich SS, et al. (2018) The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity. Cell 173: 1098-1110.
96. Cheng V, Tang B, Wu A, Chu C, Yuen K (2004) Medical treatment of viral pneumonia including SARS in immunocompetent adult. J. Infect. 49: 262–273.
97. Wu Q, et al. (2017) Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci. Rep. 7: 9110.
98. Maestroni GJM, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. J. Neuroimmunol. 13: 19–30.
99. Maestroni GJ, Conti A, Pierpaoli W (1987) Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism. Clin. Exp. Immunol. 68: 384–91.
100. Cuzzocrea S, et al. (1997) Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal Res. 23: 106–116.
101. Cuzzocrea S, Zingarelli B, Costantino G, Caputi AP (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25: 24–33.
102. Costantino G, Cuzzocrea S, Mazzon E, Caputi AP (1998) Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation. Eur. J. Pharmacol. 363: 57–63.
103. Gitto E, et al. (2001) Effects of melatonin treatment in septic newborns. Pediatr. Res. 50: 756–760.
104. Zhao Q, et al. (2018) Melatonin attenuates the inflammatory response via inhibiting the C/EBP homologous protein-mediated pathway in taurocholate-induced acute pancreatitis. Int. J. Mol. Med. 42: 3513–3521.
105. Mannino G, et al. (2019)Melatonin reduces inflammatory response in human intestinal epithelial cells stimulated by interleukin‐1β. J. Pineal Res. 67: e12598.
106. Dai W, et al. (2019) Melatonin prevents sepsis-induced renal injury via the PINK1/Parkin1 signaling pathway. Int. J. Mol. Med. 44: 1197–1204.
107. Sung PH, et al. (2018) Melatonin attenuated brain death tissue extract-induced cardiac damage by suppressing DAMP signaling. Oncotarget 9: 3531–3548.
108. Srinivasan V, Mohamed M, Kato H (2012) Melatonin in bacterial and viral infections with focus on sepsis: A Review. Recent Pat. Endocr. Metab. Immune Drug Discov. 6: 30–39.
109. Luo J, et al. (2018) Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice. Int. Immunopharmacol. 64: 116–122.
110. Hu Y, et al. (2017) Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats. Oncotarget 8: 31638–31654.
111. Ge W, et al. (2019) Melatonin protects against lipopolysaccharide-induced epididymitis in sheep epididymal epithelial cells in vitro. Immunol. Lett. 214: 45–51.
112. Chamanara M, et al. (2019) Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology 27: 361–371.
113. Xu X, et al. (2018) Melatonin suppresses TLR9-triggered proinflammatory cytokine production in macrophages by inhibiting ERK1/2 and AKT activation. Sci. Rep. 8: 15579.
114. Martinon F (2008) Detection of immune danger signals by NALP3. J. Leukoc. Biol. 83: 507–511.
115. García JA, et al. (2015) Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice. FASEB J. 29: 3863–3875.
116. Slominski AT, et al. (2014) RORα and RORγ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J. 28: 2775–2789.
117. Slominski AT, Zmijewski MA, Jetten AM (2016) RORα is not a receptor for melatonin (response to DOI 10.1002/bies.201600018). Bioessays 38: 1193-1194.
118. Rahim I, et al. (2017) Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis. J. Pineal Res. 63: e12410.
119. Hu X, et al. (2018) Melatonin inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in lipopolysaccharide-induced endometritis in mice. Int. Immunopharmacol. 64: 101–109.
120. Arioz BI; et al. (2019) Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway. Front. Immunol. 10: 1511.
121. Wang X, et al. (2019) Melatonin alleviates cigarette smoke-induced endothelial cell pyroptosis through inhibiting ROS/NLRP3 axis. Biochem. Biophys. Res. Commun. 519: 402–408.
122. Fernández-Gil B, et al. (2017) Melatonin protects rats from radiotherapy-induced small intestine toxicity. PLoS One 12: e0174474.
123. Cao Z, et al. (2017) Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J. Pineal Res. 62: e12389.
124. Wu HM, et al. (2019) Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome. Life Sci. 239: 117067.
125. Mohanty A, Tiwari-Pandey R, Pandey NR (2019) Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response. J. Cell Commun. Signal. 13: 303–318.
126. Chen Y, Zhou Z, Min W (2018) Mitochondria, oxidative stress and innate immunity. Front. Physiol. 9: 1487.
127. Rodríguez-Nuevo A, Zorzano A (2019) The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress 3: 195–207.
128. Tan DX, Manchester LC, Qin L, Reiter RJ (2016) Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int. J. Mol. Sci. 17: 2124.
129. Reiter RJ, et al. (2017) Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell. Mol. Life Sci. 74: 3863–3881.
130. Majumdar S, Nandi D Thymic atrophy: experimental studies and therapeutic interventions. Scand. J. Immunol. 87: 4–14.
131. Tian YM, Zhang GY, Dai YR (2003) Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice. Immunol. Lett. 88: 101–104.
132. Oner H, et al. (2004) Possible effects of melatonin on thymus gland after pinealectomy in rats. Neuro Endocrinol. Lett. 25: 115–118.
133. Ren W, et al. (2017) Melatonin signaling in T cells: Functions and applications. J. Pineal Res. 62: e12394.
134. Maestroni GJ, Conti A (1990) The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties. J. Neuroimmunol. 28: 167–176.
135. Pozo D, Garcia-Maurino S, Guerrero JM, Calvo JR (2004) mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT1, and hydroxindole-O-methyltransferase in different populations of human immune cells. J. Pineal Res. 37: 48–54.
136. Hardeland R (2018) Melatonin and retinoid orphan receptors: Demand for new interpretations after their exclusion as nuclear melatonin receptors. Melatonin Res. 1: 77–92.
137. Li J, Cao J, Wang Z, Dong Y, Chen Y (2015) Melatonin plays a critical role in inducing B lymphocyte proliferation of the bursa of Fabricius in broilers via monochromatic lights. J. Photochem. Photobiol. B Biol. 142: 29–34.
138. Lopez-Gonzalez MA, Guerrero JM, Sanchez B, Delgado F (1998) Melatonin restores and enhances the human type B tonsillar lymphocyte subset in recurrent acute tonsillitis. Neurosci. Lett. 247: 131–134.
139. Yu Q, Miller SC, Osmond DG (2000) Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J. Pineal Res. 29: 86–93.
140. Ramos A, et al. (2010) Evolution of oxidative/nitrosative stress biomarkers during an open-field vaccination procedure in sheep: effect of melatonin. Vet. Immunol. Immunopathol. 133: 16–24.
141. Ramos A, et al. (2018) Melatonin enhances responsiveness to Dichelobacter nodosus vaccine in sheep and increases peripheral blood CD4 T lymphocytes and IgG-expressing B lymphocytes. Vet. Immunol. Immunopathol. 206: 1–8.
142. Regodón S, et al. (2005) The use of melatonin as a vaccine agent. Vaccine 23: 5321–5327.
143. Lardone PJ, et al. (2011) Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J. Pineal Res. 51: 454–462.
144. Tan DX, et al. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472: 206–214.
145. Gómez-Corvera A, et al. (2009) Evidence of immune system melatonin production by two pineal melatonin deficient mice, C57BL/6 and Swiss strains. J. Pineal Res. 47: 15–22.
146. Naranjo MC, et al. (2007) Melatonin biosynthesis in the thymus of humans and rats. Cell. Mol. Life Sci. 64: 781–790.
147. Hardeland R. (2013) Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J. Pineal Res. 55: 325–356.
148. Elmahallawy E, et al. (2015) Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research. Curr. Med. Chem. 22, 3848–3861.
149. Bagnaresi P, Nakabashi M, Thomas AP, Reiter RJ, Garcia CRS (2012) The role of melatonin in parasite biology. Mol. Biochem. Parasitol. 181: 1–6.
150. Madigan AP, Egidi E, Bedon F, Franks AE, Plummer KM (2019) Bacterial and fungal communities are differentially modified by melatonin in agricultural soils under abiotic stress. Front. Microbiol. 10: 2616.
151. Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ (2008) Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J. Pineal Res. 44: 222–226.
152. He C, et al. (2016) Mitochondria synthesize melatonin to ameliorate its function and improve mice oocyte’s quality under in vitro conditions. Int. J. Mol. Sci. 17: 939.
153. Quintela T, Gonçalves I, Silva M, et al. (2018) Choroid plexus is an additional source of melatonin in the brain. J. Pineal Res. 65: e12528.
154. Wang L, et al. (2017) Plant mitochondria synthesize melatonin and enhance the tolerance of plants to drought stress. J. Pineal Res. 63: e12429.
155. Jiao J, et al. (2016) Melatonin-producing endophytic bacteria from grapevine roots promote the abiotic stress-induced production of endogenous melatonin in their hosts. Front. Plant Sci. 7: 1387.
156. Nehela Y, Killiny N (2018) Infection with phytopathogenic bacterium inhibits melatonin biosynthesis, decreases longevity of its vector, and suppresses the free radical-defense. J. Pineal Res. 65: e12511.
157. Chen X, et al. (2018) Melatonin Treatment Inhibits the Growth of Xanthomonas oryzae pv. oryzae. Front. Microbiol. 9: 2280.
158. Chatel-Chaix L, et al. (2016) Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe 20: 342–356.
159. Zhang L, Qin Y, Chen M (2018) Viral strategies for triggering and manipulating mitophagy. Autophagy 14: 1665–1673.
160. Ahmadi-Motamayel F, Vaziri-Amjad S, Goodarzi MT, Samie L, Poorolajal J (2017) Evaluation of salivary melatonin levels in HIV-positive patients: a historical cohort study. Rev. Recent Clin. Trials 12: 168–173.
161. Nunnari G, et al. (2003) Reduction of serum melatonin levels in HIV-1-infected individuals’ parallel disease progression: correlation with serum interleukin-12 levels. Infection 31: 379–382.
162. Ma Y, et al (2018) The reduced level of plasma melatonin in HFRS patients is correlated with disease severity and stage. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 34: 1027-1031.
163. Zhao L, et al. (2015) Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling. J. Pineal Res. 59: 230–239.
164. Wen H, Lei Y, Eun SY, Ting JPY (2010) Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 207: 2943–2957.
165. Siu KL, et al. (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 33: 8865-8877.
166. Xu L, et al. (2019) Protective effect of melatonin against polymicrobial sepsis is mediated by the anti-bacterial effect of neutrophils. Front. Immunol. 10: 1371.
167. Crespo E, et al. (1999) Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J. 13: 1537-1546.
168. Escames G, et al (2003) Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J. 17: 932-934.
169. López LC, et al. (2006) Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin. Int. J. Biochem. Cell Biol. 38: 267–278.
170. Escames G, et al. (2006) Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J. Pineal Res. 40: 71–78.
171. Escames G, et al. (2006) Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp. Gerontol. 41: 1165–1173.
172. Escames G, et al. (2006) Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J. Pharm. Pharmacol. 58: 1153–1165.
173. Ellis LC (1996) Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J. Pineal Res. 21: 214–217.
174. Ben-Nathan D, Maestroni GJ, Lustig S, Conti A (1995) Protective effects of melatonin in mice infected with encephalitis viruses. Arch. Virol. 140: 223–30.
175. Bonilla E, Valero-Fuenmayor N, Pons H, Chacín-Bonilla L (1997) Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Cell. Mol. Life Sci. 53: 430–434.
176. Araghi-Niknam M, Lane L, Watson RR (1998) Physical inactivity of murine retrovirus infected C57bl/6 mice is prevented by melatonin and dehydroepiandrosterone. Exp. Biol. Med. 219: 144–148.
177. Huang SH, Cao XJ, Liu W, Shi XY, Wei W (2010) Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J. Pineal Res. 48: 109–116.
178. Tuñón MJ, et al. (2011) Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res. 50: 38–45.
179. Tang X, et al. (2020) On the origin and continuing evolution of SARS-CoV-2. Natl. Sci. Rev. 2020: nwaa036. doi.org/10.1093/nsr/nwaa036
180. Wong MC (2020) Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv 2020: 02.07.939207. doi:10.1101/2020.02.07.939207
181. Zhang T, Wu Q, Zhang Z. (2020) Pangolin homology associated with 2019-nCoV. bioRxiv 2020: 02.19.950253. doi: 10.1101/2020.02.19.950253
182. Virk RK, Gunalan V, Tambyah PA (2016) Influenza infection in human host: Challenges in making a better influenza vaccine. Expert Rev. Anti Infect. Ther. 14: 365–375.
183. Petrova VN, Russell CA (2018) The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16: 47-60.
184. Zhou Y, et al. (2020) Network-based repurposing for human coronavirus. medRxiv 2020: 02.03.2020263. doi: 10.1101/2020.02. 03.2020263
185. Weishaupt JH, et al. (2006) Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 41: 313-321.
186. Goeijenbier M, et al. (2014) Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis. Neth. J. Med. 72: 442–448.
187. Baize S, et al. (2002) Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128: 163–168.
188. Anderson G, Maes M, Markus RP, Rodriguez M (2015) Ebola virus: melatonin as a readily available treatment option. J. Med. Virol. 87: 537–543.
189. Tan DX, Korkmaz A, Reiter RJ, Manchester LC (2014) Ebola virus disease: potential use of melatonin as a treatment. J. Pineal Res. 57: 381–384.
190. Masters A, Pandi-Perumal SR, Seixas A, Girardin JL, McFarlane SI (2014) Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment. Brain Disord. Ther. 4: doi: 10.4172/2168-975X.1000151
191. Junaid A, et al. (2020) Ebola hemorrhagic shock syndrome-on-a-chip. iScience 23: 100765.
192. Voordouw BC, et al. (1992) Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J. Clin. Endocrinol. Metab. 74: 108–117.
2. Millet JK, Whittaker GR (2015) Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202: 120–134.
3. de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ (2018) Host factors in coronavirus replication. Curr. Top. Microbiol. Immunol. 419: 1–42.
4. Gao J, Tian Z, Yang X (2020) Breakthrough: Chloroquine phosphate has shown apparent efficiacy in treatment of COVID-19 associated prneumonia in clinical studies. BioSci. Trends 14 (1): 72-73. doi: 10. 5582/bst.2020.01047.
5. Hoffmann M, et al. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. Cell. doi: 10.1016/j.cell.2020.02,052.
6. Chen IY, et al. (2019) Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front. Microbiol. 10: 50.
7. Siu KL, et al. (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 33: 8865–8877.
8. Bancos S, Bernard MP, Topham DJ, Phipps RP (2009) Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell. Immunol. 258: 18–28.
9. Hardeland R (2018) Melatonin and inflammation —Story of a double-edged blade. J. Pineal Res. 65: e12525.
10. Hattori A, et al. (1995) Identification of melatonin in plants and its effects on plasma melatonin levels and binding to melatonin receptors in vertebrates. Biochem. Mol. Biol. Int. 35: 627–34.
11. Oba S, Nakamura K, Sahashi Y, Hattori A, Nagata C (2008) Consumption of vegetables alters morning urinary 6-sulfatoxymelatonin concentration. J. Pineal Res. 45: 17–23.
12. Howatson G, et al. (2012) Effect of tart cherry juice (Prunus cerasus) on melatonin levels and enhanced sleep quality. Eur. J. Nutr. 51: 909–916.
13. 13. Reiter, R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12, 151–180 (1991).
14. Hardeland R (2012) Melatonin in aging and disease ― multiple consequences of reduced secretion, options and limits of treatment. Aging Dis. 3: 194–225.
15. Tan DX, Chen L, Poeggeler B, Manchester LC, Reiter JR (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1: 57–63.
16. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ (2007) One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species? J. Pineal Res. 42: 28–42.
17. Davalli P, Mitic T, Caporali A, Lauriola A, D’Arca D (2016) ROS, cell senescence, and novel molecular mechanisms in aging and age-related diseases. Oxid. Med. Cell. Longev. 2016：1–18.
18. Baumann CW, Kwak D, Liu HM, Thompson LV (2016) Age-induced oxidative stress: how does it influence skeletal muscle quantity and quality? J. Appl. Physiol. 121: 1047–1052.
19. Pohjanvirta R, Tuomisto J, Linden J, Laitinen J (1989) TCDD Reduces Serum Melatonin Levels in Long-Evans Rats. Pharmacol. Toxicol. 65: 239–240 (1989).
20. Linden J, Pohjanvirta R, Rahko T, Tuomisto J TCDD (1991) Decreases Rapidly and persistently serum melatonin concentration without morphologically affecting the pineal gland in TCDD-resistant Han/Wistar rats. Pharmacol. Toxicol. 69: 427–432.
21. Pohjanvirta R, et al. (1996) Mechanism by which 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reduces circulating melatonin levels in the rat. Toxicology 107: 85–97.
22. Ozcankaya, Delibas N (2002) Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study. Croat. Med. J. 43: 28–32.
23. Uchida K, Okamoto N, Ohara K, Morita Y (1996) Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717: 154–159.
24. Dominguez-Rodriguez A, Abreu-Gonzalez P, Arroyo-Ucar E, Reiter RJ (2012) Decreased level of melatonin in serum predicts left ventricular remodelling after acute myocardial infarction. J. Pineal Res. 53: 319–323.
25. Dzida G, et al. (2013) Alteration in diurnal and nocturnal melatonin serum level in patients with chronic heart failure. Ann. Agric. Environ. Med. 20: 745–748.
26. Hardeland R (2012) Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Scientific World Journal 2012: 640389.
27. Uz T, Qu T, Sugaya K, Manev H (2002) Neuronal expression of arylalkylamine N-acetyltransferase (AANAT) mRNA in the rat brain. Neurosci. Res. 42: 309–316.
28. Klein DC, et al. (2002) 14-3-3 Proteins and photoneuroendocrine transduction: role in controlling the daily rhythm in melatonin. Biochem. Soc. Trans. 30: 365–373.
29. Hardeland R (2008) Melatonin, hormone of darkness and more – occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. 65: 2001–2018.
30. Hardeland R, et al. (2011) Melatonin – A pleiotropic, orchestrating regulator molecule. Prog. Neurobiol. 93: 350–384.
31. Tan DX, et al. (2013) Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin’s primary function and evolution in eukaryotes. J. Pineal Res. 54: 127–138.
32. Tan DX, Reiter RJ (2019) Mitochondria: the birth place, battle ground and the site of melatonin metabolism in cells. Melatonin Res. 2: 44–66.
33. Suofu Y, et al. (2017) Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proc. Natl. Acad. Sci. 114: E7997–E8006.
34. Huether G (1993)The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates. Experientia 49: 665–670.
35. Bubenik GA (2002) Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 47: 2336–2348.
36. Hardeland R (2017) Melatonin and the electron transport chain. Cell. Mol. Life Sci. 74: 3883–3896.
37. Hardeland R, et al. (1995) On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18: 104–111.
38. Tan DX, et al. (2010) The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol. Rev. Camb. Philos. Soc. 85: 607–623.
39. Boehm T, Swann JB (2014) Origin and evolution of adaptive immunity. Annu. Rev. Anim. Biosci. 2: 259–283.
40. Buchon N, et al. (2014) Immunity in Drosophila melanogaster—from microbial recognition to whole-organism physiology. Nat. Rev. Immunol. 14: 796–810.
41. Zhang X, Soldati T (2016) Of amoebae and men: Extracellular DNA traps as an ancient cell-Intrinsic defense mechanism. Front. Immunol. 7: 269.
42. Tan DX (2019) Aging: An evolutionary competition between host cells and mitochondria. Med. Hypotheses 127: 120–128.
43. Csaba G (2013) The pineal regulation of the immune system: 40 years since the discovery. Acta Microbiol. Immunol. Hung. 60: 77–91.
44. Mańka S, Majewska E (2016) Immunoregulatory action of melatonin. The mechanism of action and the effect on inflammatory cells. Postepy Hig. Med. Dosw. 70: 1059–1067.
45. Markus RP, Fernandes PA, Kinker GS, da Silveira Cruz-Machado S, Marçola M (2018) Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br. J. Pharmacol. 175: 3239–3250.
46. Boga, JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ (2012) Beneficial actions of melatonin in the management of viral infections: a new use for this “molecular handyman”? Rev. Med. Virol. 22: 323–338.
47. Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR (2015) Melatonin and brain inflammaging. Prog. Neurobiol. 127–128: 46–63.
48. Hardeland R. (2019) Aging, melatonin, and the pro- and anti-inflammatory networks. Int. J. Mol. Sci. 20: 1223.
49. Xia Y, et al. (2019) Melatonin in macrophage biology: Current understanding and future perspectives. J. Pineal Res. 66: e12547.
50. Lu R, et al. (2019) Melatonin is responsible for rice resistance to rice stripe virus infection through a nitric oxide-dependent pathway. Virol. J. 16: 141.
51. Ouyang H, et al. (2019) Inhibitory effect of melatonin on Mst1 ameliorates myocarditis through attenuating ER stress and mitochondrial dysfunction. J. Mol. Histol. 50: 405–415.
52. Kılınçel Ö, et al. (2019) The effect of melatonin on antifungal susceptibility in planktonic and biofilm forms of Candida strains isolated from clinical samples. Med. Mycol. 57: 45–51.
53. Bishayi B, Adhikary R, Nandi A, Sultana S (2016) Beneficial Effects of exogenous melatonin in acute staphylococcus aureus and escherichia coli infection-induced inflammation and associated behavioral response in mice after exposure to short photoperiod. Inflammation 39: 2072–2093.
54. Safari F, et al. (2020) The interaction of phages and bacteria: the co-evolutionary arms race. Crit. Rev. Biotechnol. 40: 119–137.
55. Prangishvili D, et al. (2017) The enigmatic archaeal virosphere. Nat. Rev. Microbiol. 15, 724–739.
56. Aiewsakun P, et al. (2018) Evaluation of the genomic diversity of viruses infecting bacteria, archaea and eukaryotes using a common bioinformatic platform: steps towards a unified taxonomy. J. Gen. Virol. 99: 1331–1343.
57. Horvath P, Barrangou R (2010) CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167–170.
58. Bhaya D, Davison M, Barrangou R (2011) CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu. Rev. Genet. 45: 273–297.
59. Hampton HG, Watson BNJ, Fineran PC (2020) The arms race between bacteria and their phage foes. Nature 577: 327–336.
60. Kumar MS, Chen KC (2012) Evolution of animal Piwi-interacting RNAs and prokaryotic CRISPRs. Evolution of animal Piwi-interacting RNAs and prokaryotic CRISPRs. Brief Funct. Genomics 11: 277–288.
61. Ophinni Y, Palatini U, Hayashi Y, Parrish NF (2019) piRNA-guided CRISPR-like immunity in eukaryotes. Trends Immunol. 40: 998–1010.
62. Danilova N (2006) The evolution of immune mechanisms. J. Exp. Zool. Part B Mol. Dev. Evol. 306B: 496–520.
63. Amano A, Nakagawa I, Yoshimori T (2006) Autophagy in innate immunity against intracellular bacteria. J. Biochem. 140: 161–166.
64. Shimada K, et al. (2012) Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401–414.
65. Glück S, Ablasser A (2018) Innate immunosensing of DNA in cellular senescence. Curr. Opin. Immunol. 56: 31–36.
66. Ma Z, Ni G, Damania B (2018) Innate sensing of DNA virus genomes. Annu. Rev. Virol. 5: 341–362.
67. Rongvaux A (2018) Innate immunity and tolerance toward mitochondria. Mitochondrion 41: 14–20.
68. Boehm T, et al. (2018) Evolution of alternative adaptive immune systems in vertebrates. Annu. Rev. Immunol. 36: 19–42.
69. Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultz, JL (2019) Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens. Cell Host Microbe 25: 13–26.
70. Brilot F, Strowig T, Munz C (2008) NK cells interactions with dendritic cells shape innate and adaptive immunity. Front. Biosci. 13: 6443–6454.
71. Reschner A, et al. (2008) Innate lymphocyte and dendritic cell cross-talk: a key factor in the regulation of the immune response. Clin. Exp. Immunol. 152: 219–226.
72. Moretta L, et al. (2006) Surface NK receptors and their ligands on tumor cells.Semin. Immunol. 18: 151-158.
73. Rajalingam R (2018) Diversity of killer cell immunoglobulin-like receptors and disease. Clin. Lab. Med. 38: 637-653.
74. Kumar V, McNerney ME (2005) A new self: MHC-class-I-independent Natural-killer-cell self-tolerance. Nat. Rev. Immunol. 5, 363–374.
75. Lodoen MB, Lanier LL (2005) Viral modulation of NK cell immunity. Nat. Rev. Microbiol. 3: 59–69.
76. Werling D, Jungi TW (2003) TOLL-like receptors linking innate and adaptive immune response. Vet. Immunol. Immunopathol. 91: 1–12.
77. Luecke S, Paludan SR (2015) Innate recognition of alphaherpesvirus DNA. Adv. Virus Res. 92: 63–100.
78. Sepehri Z, Kiani Z, Alavian SM, Arababadi MK, Kennedy D (2016) The link between TLR7 signaling and hepatitis B virus infection. Life Sci. 158: 63–69.
79. Petes C, Odoardi N, Gee K (2017) The toll for trafficking: toll-like receptor 7 delivery to the endosome. Front. Immunol. 8: 1075.
80. Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol. Rev. 227: 75–86.
81. Zhou L, et al. (2015) Induction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells. Mol. Hum. Reprod. 21: 917–929.
82. Muruve DA, et al. (2008) The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103–107.
83. Roberts TL, et al. (2009) HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057–1060.
84. Broz P, Dixit VM (2016) Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16: 407–420.
85. Winsor N, et al. (2019) Canonical and noncanonical inflammasomes in intestinal epithelial cells. Cell. Microbiol. 21: e13079.
86. Al-Omari A, Rabaan AA, Salih S, Al-Tawfiq JA, Memish ZA (2019) MERS coronavirus outbreak: Implications for emerging viral infections. Diagn. Microbiol. Infect. Dis. 93: 265–285.
87. Rojek AM, et al. (2019) A systematic review and meta-analysis of patient data from the West Africa (2013–16) Ebola virus disease epidemic. Clin. Microbiol. Infect. 25: 1307–1314.
88. Chen J, Subbarao K (2007) The Immunobiology of SARS. Annu. Rev. Immunol. 25: 443–472.
89. Paget J, et al. (2019) Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project. J. Glob. Health 9: 020421.
90. Messaoudi I, Amarasinghe GK, Basler CF (2015) Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. Nat. Rev. Microbiol. 13: 663–676.
91. Baseler L, et al. (2017) The pathogenesis of Ebola virus disease. Annu. Rev. Pathol. 12: 387-418.
92. Oldstone MBA, Rosen H (2014) Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. in Current topics in microbiology and immunology 378: 129–147.
93. Wong JP, et al. (2017) Current and future developments in the treatment of virus-induced hypercytokinemia. Future Med. Chem. 9: 169–178.
94. Refardt D, Kümmerli R (2013) Defying bacteriophages: Contrasting altruistic with individual-based resistance mechanisms in Escherichia coli. Commun. Integr. Biol. 6: e25159.
95. Pavlovich SS, et al. (2018) The Egyptian Rousette Genome Reveals Unexpected Features of Bat Antiviral Immunity. Cell 173: 1098-1110.
96. Cheng V, Tang B, Wu A, Chu C, Yuen K (2004) Medical treatment of viral pneumonia including SARS in immunocompetent adult. J. Infect. 49: 262–273.
97. Wu Q, et al. (2017) Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci. Rep. 7: 9110.
98. Maestroni GJM, Conti A, Pierpaoli W (1986) Role of the pineal gland in immunity. J. Neuroimmunol. 13: 19–30.
99. Maestroni GJ, Conti A, Pierpaoli W (1987) Role of the pineal gland in immunity: II. Melatonin enhances the antibody response via an opiatergic mechanism. Clin. Exp. Immunol. 68: 384–91.
100. Cuzzocrea S, et al. (1997) Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal Res. 23: 106–116.
101. Cuzzocrea S, Zingarelli B, Costantino G, Caputi AP (1998) Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J. Pineal Res. 25: 24–33.
102. Costantino G, Cuzzocrea S, Mazzon E, Caputi AP (1998) Protective effects of melatonin in zymosan-activated plasma-induced paw inflammation. Eur. J. Pharmacol. 363: 57–63.
103. Gitto E, et al. (2001) Effects of melatonin treatment in septic newborns. Pediatr. Res. 50: 756–760.
104. Zhao Q, et al. (2018) Melatonin attenuates the inflammatory response via inhibiting the C/EBP homologous protein-mediated pathway in taurocholate-induced acute pancreatitis. Int. J. Mol. Med. 42: 3513–3521.
105. Mannino G, et al. (2019)Melatonin reduces inflammatory response in human intestinal epithelial cells stimulated by interleukin‐1β. J. Pineal Res. 67: e12598.
106. Dai W, et al. (2019) Melatonin prevents sepsis-induced renal injury via the PINK1/Parkin1 signaling pathway. Int. J. Mol. Med. 44: 1197–1204.
107. Sung PH, et al. (2018) Melatonin attenuated brain death tissue extract-induced cardiac damage by suppressing DAMP signaling. Oncotarget 9: 3531–3548.
108. Srinivasan V, Mohamed M, Kato H (2012) Melatonin in bacterial and viral infections with focus on sepsis: A Review. Recent Pat. Endocr. Metab. Immune Drug Discov. 6: 30–39.
109. Luo J, et al. (2018) Melatonin mediated Foxp3-downregulation decreases cytokines production via the TLR2 and TLR4 pathways in H. pylori infected mice. Int. Immunopharmacol. 64: 116–122.
110. Hu Y, et al. (2017) Melatonin protects against blood-brain barrier damage by inhibiting the TLR4/ NF-κB signaling pathway after LPS treatment in neonatal rats. Oncotarget 8: 31638–31654.
111. Ge W, et al. (2019) Melatonin protects against lipopolysaccharide-induced epididymitis in sheep epididymal epithelial cells in vitro. Immunol. Lett. 214: 45–51.
112. Chamanara M, et al. (2019) Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology 27: 361–371.
113. Xu X, et al. (2018) Melatonin suppresses TLR9-triggered proinflammatory cytokine production in macrophages by inhibiting ERK1/2 and AKT activation. Sci. Rep. 8: 15579.
114. Martinon F (2008) Detection of immune danger signals by NALP3. J. Leukoc. Biol. 83: 507–511.
115. García JA, et al. (2015) Disruption of the NF-κB/NLRP3 connection by melatonin requires retinoid-related orphan receptor-α and blocks the septic response in mice. FASEB J. 29: 3863–3875.
116. Slominski AT, et al. (2014) RORα and RORγ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J. 28: 2775–2789.
117. Slominski AT, Zmijewski MA, Jetten AM (2016) RORα is not a receptor for melatonin (response to DOI 10.1002/bies.201600018). Bioessays 38: 1193-1194.
118. Rahim I, et al. (2017) Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis. J. Pineal Res. 63: e12410.
119. Hu X, et al. (2018) Melatonin inhibits endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation in lipopolysaccharide-induced endometritis in mice. Int. Immunopharmacol. 64: 101–109.
120. Arioz BI; et al. (2019) Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway. Front. Immunol. 10: 1511.
121. Wang X, et al. (2019) Melatonin alleviates cigarette smoke-induced endothelial cell pyroptosis through inhibiting ROS/NLRP3 axis. Biochem. Biophys. Res. Commun. 519: 402–408.
122. Fernández-Gil B, et al. (2017) Melatonin protects rats from radiotherapy-induced small intestine toxicity. PLoS One 12: e0174474.
123. Cao Z, et al. (2017) Melatonin alleviates cadmium-induced liver injury by inhibiting the TXNIP-NLRP3 inflammasome. J. Pineal Res. 62: e12389.
124. Wu HM, et al. (2019) Melatonin biosynthesis restored by CpG oligodeoxynucleotides attenuates allergic airway inflammation via regulating NLRP3 inflammasome. Life Sci. 239: 117067.
125. Mohanty A, Tiwari-Pandey R, Pandey NR (2019) Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response. J. Cell Commun. Signal. 13: 303–318.
126. Chen Y, Zhou Z, Min W (2018) Mitochondria, oxidative stress and innate immunity. Front. Physiol. 9: 1487.
127. Rodríguez-Nuevo A, Zorzano A (2019) The sensing of mitochondrial DAMPs by non-immune cells. Cell Stress 3: 195–207.
128. Tan DX, Manchester LC, Qin L, Reiter RJ (2016) Melatonin: A mitochondrial targeting molecule involving mitochondrial protection and dynamics. Int. J. Mol. Sci. 17: 2124.
129. Reiter RJ, et al. (2017) Melatonin as a mitochondria-targeted antioxidant: one of evolution’s best ideas. Cell. Mol. Life Sci. 74: 3863–3881.
130. Majumdar S, Nandi D Thymic atrophy: experimental studies and therapeutic interventions. Scand. J. Immunol. 87: 4–14.
131. Tian YM, Zhang GY, Dai YR (2003) Melatonin rejuvenates degenerated thymus and redresses peripheral immune functions in aged mice. Immunol. Lett. 88: 101–104.
132. Oner H, et al. (2004) Possible effects of melatonin on thymus gland after pinealectomy in rats. Neuro Endocrinol. Lett. 25: 115–118.
133. Ren W, et al. (2017) Melatonin signaling in T cells: Functions and applications. J. Pineal Res. 62: e12394.
134. Maestroni GJ, Conti A (1990) The pineal neurohormone melatonin stimulates activated CD4+, Thy-1+ cells to release opioid agonist(s) with immunoenhancing and anti-stress properties. J. Neuroimmunol. 28: 167–176.
135. Pozo D, Garcia-Maurino S, Guerrero JM, Calvo JR (2004) mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT1, and hydroxindole-O-methyltransferase in different populations of human immune cells. J. Pineal Res. 37: 48–54.
136. Hardeland R (2018) Melatonin and retinoid orphan receptors: Demand for new interpretations after their exclusion as nuclear melatonin receptors. Melatonin Res. 1: 77–92.
137. Li J, Cao J, Wang Z, Dong Y, Chen Y (2015) Melatonin plays a critical role in inducing B lymphocyte proliferation of the bursa of Fabricius in broilers via monochromatic lights. J. Photochem. Photobiol. B Biol. 142: 29–34.
138. Lopez-Gonzalez MA, Guerrero JM, Sanchez B, Delgado F (1998) Melatonin restores and enhances the human type B tonsillar lymphocyte subset in recurrent acute tonsillitis. Neurosci. Lett. 247: 131–134.
139. Yu Q, Miller SC, Osmond DG (2000) Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J. Pineal Res. 29: 86–93.
140. Ramos A, et al. (2010) Evolution of oxidative/nitrosative stress biomarkers during an open-field vaccination procedure in sheep: effect of melatonin. Vet. Immunol. Immunopathol. 133: 16–24.
141. Ramos A, et al. (2018) Melatonin enhances responsiveness to Dichelobacter nodosus vaccine in sheep and increases peripheral blood CD4 T lymphocytes and IgG-expressing B lymphocytes. Vet. Immunol. Immunopathol. 206: 1–8.
142. Regodón S, et al. (2005) The use of melatonin as a vaccine agent. Vaccine 23: 5321–5327.
143. Lardone PJ, et al. (2011) Melatonin synthesized by T lymphocytes as a ligand of the retinoic acid-related orphan receptor. J. Pineal Res. 51: 454–462.
144. Tan DX, et al. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472: 206–214.
145. Gómez-Corvera A, et al. (2009) Evidence of immune system melatonin production by two pineal melatonin deficient mice, C57BL/6 and Swiss strains. J. Pineal Res. 47: 15–22.
146. Naranjo MC, et al. (2007) Melatonin biosynthesis in the thymus of humans and rats. Cell. Mol. Life Sci. 64: 781–790.
147. Hardeland R. (2013) Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J. Pineal Res. 55: 325–356.
148. Elmahallawy E, et al. (2015) Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research. Curr. Med. Chem. 22, 3848–3861.
149. Bagnaresi P, Nakabashi M, Thomas AP, Reiter RJ, Garcia CRS (2012) The role of melatonin in parasite biology. Mol. Biochem. Parasitol. 181: 1–6.
150. Madigan AP, Egidi E, Bedon F, Franks AE, Plummer KM (2019) Bacterial and fungal communities are differentially modified by melatonin in agricultural soils under abiotic stress. Front. Microbiol. 10: 2616.
151. Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ (2008) Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J. Pineal Res. 44: 222–226.
152. He C, et al. (2016) Mitochondria synthesize melatonin to ameliorate its function and improve mice oocyte’s quality under in vitro conditions. Int. J. Mol. Sci. 17: 939.
153. Quintela T, Gonçalves I, Silva M, et al. (2018) Choroid plexus is an additional source of melatonin in the brain. J. Pineal Res. 65: e12528.
154. Wang L, et al. (2017) Plant mitochondria synthesize melatonin and enhance the tolerance of plants to drought stress. J. Pineal Res. 63: e12429.
155. Jiao J, et al. (2016) Melatonin-producing endophytic bacteria from grapevine roots promote the abiotic stress-induced production of endogenous melatonin in their hosts. Front. Plant Sci. 7: 1387.
156. Nehela Y, Killiny N (2018) Infection with phytopathogenic bacterium inhibits melatonin biosynthesis, decreases longevity of its vector, and suppresses the free radical-defense. J. Pineal Res. 65: e12511.
157. Chen X, et al. (2018) Melatonin Treatment Inhibits the Growth of Xanthomonas oryzae pv. oryzae. Front. Microbiol. 9: 2280.
158. Chatel-Chaix L, et al. (2016) Dengue virus perturbs mitochondrial morphodynamics to dampen innate immune responses. Cell Host Microbe 20: 342–356.
159. Zhang L, Qin Y, Chen M (2018) Viral strategies for triggering and manipulating mitophagy. Autophagy 14: 1665–1673.
160. Ahmadi-Motamayel F, Vaziri-Amjad S, Goodarzi MT, Samie L, Poorolajal J (2017) Evaluation of salivary melatonin levels in HIV-positive patients: a historical cohort study. Rev. Recent Clin. Trials 12: 168–173.
161. Nunnari G, et al. (2003) Reduction of serum melatonin levels in HIV-1-infected individuals’ parallel disease progression: correlation with serum interleukin-12 levels. Infection 31: 379–382.
162. Ma Y, et al (2018) The reduced level of plasma melatonin in HFRS patients is correlated with disease severity and stage. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 34: 1027-1031.
163. Zhao L, et al. (2015) Melatonin alleviates brain injury in mice subjected to cecal ligation and puncture via attenuating inflammation, apoptosis, and oxidative stress: the role of SIRT1 signaling. J. Pineal Res. 59: 230–239.
164. Wen H, Lei Y, Eun SY, Ting JPY (2010) Plexin-A4-semaphorin 3A signaling is required for Toll-like receptor- and sepsis-induced cytokine storm. J. Exp. Med. 207: 2943–2957.
165. Siu KL, et al. (2019) Severe acute respiratory syndrome coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J. 33: 8865-8877.
166. Xu L, et al. (2019) Protective effect of melatonin against polymicrobial sepsis is mediated by the anti-bacterial effect of neutrophils. Front. Immunol. 10: 1371.
167. Crespo E, et al. (1999) Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J. 13: 1537-1546.
168. Escames G, et al (2003) Melatonin counteracts lipopolysaccharide-induced expression and activity of mitochondrial nitric oxide synthase in rats. FASEB J. 17: 932-934.
169. López LC, et al. (2006) Identification of an inducible nitric oxide synthase in diaphragm mitochondria from septic mice: its relation with mitochondrial dysfunction and prevention by melatonin. Int. J. Biochem. Cell Biol. 38: 267–278.
170. Escames G, et al. (2006) Melatonin counteracts inducible mitochondrial nitric oxide synthase-dependent mitochondrial dysfunction in skeletal muscle of septic mice. J. Pineal Res. 40: 71–78.
171. Escames G, et al. (2006) Age-dependent lipopolysaccharide-induced iNOS expression and multiorgan failure in rats: effects of melatonin treatment. Exp. Gerontol. 41: 1165–1173.
172. Escames G, et al. (2006) Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J. Pharm. Pharmacol. 58: 1153–1165.
173. Ellis LC (1996) Melatonin reduces mortality from Aleutian disease in mink (Mustela vison). J. Pineal Res. 21: 214–217.
174. Ben-Nathan D, Maestroni GJ, Lustig S, Conti A (1995) Protective effects of melatonin in mice infected with encephalitis viruses. Arch. Virol. 140: 223–30.
175. Bonilla E, Valero-Fuenmayor N, Pons H, Chacín-Bonilla L (1997) Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus. Cell. Mol. Life Sci. 53: 430–434.
176. Araghi-Niknam M, Lane L, Watson RR (1998) Physical inactivity of murine retrovirus infected C57bl/6 mice is prevented by melatonin and dehydroepiandrosterone. Exp. Biol. Med. 219: 144–148.
177. Huang SH, Cao XJ, Liu W, Shi XY, Wei W (2010) Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J. Pineal Res. 48: 109–116.
178. Tuñón MJ, et al. (2011) Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J. Pineal Res. 50: 38–45.
179. Tang X, et al. (2020) On the origin and continuing evolution of SARS-CoV-2. Natl. Sci. Rev. 2020: nwaa036. doi.org/10.1093/nsr/nwaa036
180. Wong MC (2020) Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv 2020: 02.07.939207. doi:10.1101/2020.02.07.939207
181. Zhang T, Wu Q, Zhang Z. (2020) Pangolin homology associated with 2019-nCoV. bioRxiv 2020: 02.19.950253. doi: 10.1101/2020.02.19.950253
182. Virk RK, Gunalan V, Tambyah PA (2016) Influenza infection in human host: Challenges in making a better influenza vaccine. Expert Rev. Anti Infect. Ther. 14: 365–375.
183. Petrova VN, Russell CA (2018) The evolution of seasonal influenza viruses. Nat. Rev. Microbiol. 16: 47-60.
184. Zhou Y, et al. (2020) Network-based repurposing for human coronavirus. medRxiv 2020: 02.03.2020263. doi: 10.1101/2020.02. 03.2020263
185. Weishaupt JH, et al. (2006) Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 41: 313-321.
186. Goeijenbier M, et al. (2014) Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis. Neth. J. Med. 72: 442–448.
187. Baize S, et al. (2002) Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 128: 163–168.
188. Anderson G, Maes M, Markus RP, Rodriguez M (2015) Ebola virus: melatonin as a readily available treatment option. J. Med. Virol. 87: 537–543.
189. Tan DX, Korkmaz A, Reiter RJ, Manchester LC (2014) Ebola virus disease: potential use of melatonin as a treatment. J. Pineal Res. 57: 381–384.
190. Masters A, Pandi-Perumal SR, Seixas A, Girardin JL, McFarlane SI (2014) Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment. Brain Disord. Ther. 4: doi: 10.4172/2168-975X.1000151
191. Junaid A, et al. (2020) Ebola hemorrhagic shock syndrome-on-a-chip. iScience 23: 100765.
192. Voordouw BC, et al. (1992) Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J. Clin. Endocrinol. Metab. 74: 108–117.
Published
2020-03-23
How to Cite
[1]
Tan, D.X. and Hardeland, R. 2020. Potential utility of melatonin in deadly infectious diseases related to the overreaction of innate immune response and destructive inflammation: focus on COVID-19. Melatonin Research. 3, 1 (Mar. 2020), 120-143. DOI:https://doi.org/https://doi.org/10.32794/mr11250052.
Section
Reviews
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Melatonin Res., copyright is retained by the authors. Articles are licensed under an open access Creative Commons CC BY 4.0 license, meaning that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. These conditions allow for maximum use and exposure of the work, while ensuring that the authors receive proper credit.
In exceptional circumstances articles may be licensed differently. If you have specific condition (such as one linked to funding) that does not allow this license, please mention this to the editorial office of the journal at submission. Exceptions will be granted at the discretion of the publisher.
